Related Experiment Video

Updated: Jul 14, 2026

A Modified In vitro Invasion Assay to Determine the Potential Role of Hormones, Cytokines and/or Growth Factors in Mediating Cancer Cell Invasion
06:36

A Modified In vitro Invasion Assay to Determine the Potential Role of Hormones, Cytokines and/or Growth Factors in Mediating Cancer Cell Invasion

Published on: April 24, 2015

Insulinlike growth factors and binding proteins in colon cancer

P Singh1, N Rubin

  • 1Department of Anatomy and Neurosciences, University of Texas Medical Branch, Galveston.

Gastroenterology
|October 1, 1993
PubMed

Insights

Insulinlike growth factors (IGFs) and their binding proteins (IGF-BPs) are crucial in colon cancer growth and metastasis. Understanding the IGF system is key to targeting colon cancer progression.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Oncology

Background:

  • Insulinlike growth factors (IGFs) exhibit anabolic and mitogenic effects on various cells.
  • IGFs exert endocrine, autocrine, and paracrine functions, influencing cellular activities.
  • Cellular response to IGFs is modulated by IGF membrane receptors and soluble binding proteins (BPs).

Purpose of the Study:

  • To summarize current knowledge of the Insulinlike Growth Factor (IGF) system.
  • To provide evidence supporting a significant role of IGFs in colon cancer initiation and progression.
  • To review the expression and structural aspects of IGFs, receptors, and BPs in relation to gastrointestinal functions and colon cancers.

Main Methods:

  • Literature review and synthesis of existing research on the IGF system.
  • Analysis of studies investigating IGFs, IGF receptors, and IGF-BPs in colon cancer.
  • Examination of the relationship between IGF system components and colon cancer proliferation and metastasis.

Main Results:

  • The three components of the IGF system (IGFs, IGF receptors, IGF-BPs) are implicated in colon cancer proliferation.
  • Relative expression of IGFs and IGF-BPs may critically influence the metastatic potential of colon cancers.
  • IGFs play a significant role in the initiation and growth of colon cancers.

Conclusions:

  • The IGF system is integral to the development and progression of colon cancer.
  • Further research into the IGF system's role in colon cancer is warranted.
  • Targeting the IGF system holds potential for colon cancer therapeutic strategies.

More Related Videos

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

Ex Vivo Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease06:25

Ex Vivo Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease

Published on: March 29, 2024

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...